Helene Jouin

Antibodies elicited in adults by a primary Plasmodium falciparumblood-stage infection recognize different epitopes compared with immune individuals (2007)

Eisen, Damon P, Wang, Lina, Jouin, Helene, Murhandarwati, E Elsa H, Black, Casilda G, Mercereau-Puijalon, Odile, ...

Abstract Background Asexual stage antibody responses following initial Plasmodium falciparum infections in previously healthy adults may inform vaccine development, yet these have not been as...

Assessment of Plasmodium falciparumresistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure (2006)

Daher, Wassim, Biot, Christophe, Fandeur, Thierry, Jouin, Helene, Pelinski, Lydie, Viscogliosi, Eric, ...

Abstract Background Ferroquine (FQ), or SSR97193, is a novel antimalarial drug currently in phase I clinical trials. FQ is a unique organometallic compound designed to overcome the chloroquine (CQ)...

Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure. (2006)

Daher, Wassim, Biot, Christophe, Fandeur, Thierry, Jouin, Helene, Pelinski, Lydie, Viscogliosi, Eric, ...

BACKGROUND: Ferroquine (FQ), or SSR97193, is a novel antimalarial drug currently in phase I clinical trials. FQ is a unique organometallic compound designed to overcome the chloroquine (CQ)...

Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure. (2006)

Daher, Wassim, Biot, Christophe, Fandeur, Thierry, Jouin, Helene, Pelinski, Lydie, Viscogliosi, Eric, ...

BACKGROUND: Ferroquine (FQ), or SSR97193, is a novel antimalarial drug currently in phase I clinical trials. FQ is a unique organometallic compound designed to overcome the chloroquine (CQ)...

Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure. (2006)

Daher, Wassim, Biot, Christophe, Fandeur, Thierry, Jouin, Helene, Pelinski, Lydie, Viscogliosi, Eric, ...

BACKGROUND: Ferroquine (FQ), or SSR97193, is a novel antimalarial drug currently in phase I clinical trials. FQ is a unique organometallic compound designed to overcome the chloroquine (CQ)...

Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure. (2006)

Daher, Wassim, Biot, Christophe, Fandeur, Thierry, Jouin, Helene, Pelinski, Lydie, Viscogliosi, Eric, ...

BACKGROUND: Ferroquine (FQ), or SSR97193, is a novel antimalarial drug currently in phase I clinical trials. FQ is a unique organometallic compound designed to overcome the chloroquine (CQ)...

Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure

Daher, Wassim, Biot, Christophe, Fandeur, Thierry, Jouin, Helene, Pelinski, Lydie, Viscogliosi, Eric, ...

Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure

Daher, Wassim, Biot, Christophe, Fandeur, Thierry, Jouin, Helene, Pelinski, Lydie, Viscogliosi, Eric, ...

Antibodies elicited in adults by a primary Plasmodium falciparum blood-stage infection recognize different epitopes compared with immune individuals

Eisen, Damon P, Wang, Lina, Jouin, Helene, Murhandarwati, E Elsa H, Black, Casilda G, Mercereau-Puijalon, Odile, ...